Medpace, Inc., a leading full-service global clinical research organization (CRO), today announced that they were recognized as a member of the Deloitte Cincinnati USA 100, coming in at number 34 for outstanding revenue growth as a member of the top privately held companies in the Cincinnati area. Regional companies in the greater Cincinnati area are ranked by annual sales revenue to arrive at the 100 largest, privately held companies in Cincinnati, Ohio, and the surrounding business region.
Medpace founded in 1992 has experienced rapid growth, having built a state of the art research campus in Madisonville at the corner of Madison and Red Bank Expressway. The campus houses over 1000 Medpace employees in the Corporate HQ, CRO, Labs, and Clinical Pharmacology Unit. Medpace continues to build jobs locally and abroad in the life science sector.
This is the eighth consecutive year for Medpace to be honored in the top 100 companies as a top privately held organization headquartered in Cincinnati Ohio.
Full-Service Clinical Development
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective.